For people with mental health conditions, finding a medication that works without causing severe side effects is often a matter of trial-and-error. This can contribute to a lower adherence to treatment regimens and poorer health, as well as increased costs to the health care system. Pharmacogenomics can improve a person’s health by helping them know ahead of time whether a…
Read More
Since the beginning of the COVID-19 outbreak, the Government of Canada has consulted with experts from around the world and supported Canadian researchers to help combat this new coronavirus. On March 11, 2020, the Prime Minister, Justin Trudeau, outlined an investment of $275 million to enhance Canada’s capacity in research and development, as part of Canada’s COVID-19 response, including research…
Read More
After the success of last year’s inaugural Canadian Blood Services’ Lay Science Writing Competition, we couldn’t wait to do it again! The Centre for Innovation was delighted to once again partner with science communication and research leaders Science Borealis and the Centre for Blood Research at the University of British Columbia to host this competition. This time around, we asked our research trainees to send us “Stories…
Read More
Simon Fraser University researchers will use their pioneering imaging technology—called Mango, for its bright colour— to develop coronavirus testing kits. They’re among a small set of Canadian researchers who responded to the rapid funding opportunity recently announced by the Canadian Institutes of Health Research (CIHR) to help address COVID-19. SFU researchers Lena Dolgosheina, a post-doctoral fellow and Peter Unrau, a professor of molecular…
Read More
Cross-species complementation can be used to generate humanized yeast, which is a valuable resource with which to model and study human biology. Humanized yeast can be used as an in vivo platform to screen for chemical inhibition of human protein drug targets. To this end, we report the systematic complementation of nonessential yeast genes implicated in chromosome instability (CIN) with their human…
Read More
Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has made the decision to begin production of NP-120 (Ifenprodil) with a new injectable and long acting oral release formulation, in order to be prepared for new US clinical trials for COVID-19 (coronavirus) and acute lung…
Read More
The BC Diabetes Research Network is delighted to announce episode 5  of our official podcast: “Diabetes: From Beta Cells to Bicycles“. Episode 5: Dr Robert Boushel Professor and Director, School of Kinesiology, Faculty of Education, University of British Columbia Host Krista Lamb is joined by BC Diabetes Research Network researcher and UBC professor Dr. Robert Boushel, whose research focuses on the…
Read More
Julia Hudea, a fourth-year student in the UBC mechanical engineering program’s biomedical concentration, has been awarded the Geyer Family Award in Biomedical Engineering. The award is curated by the UBC School of Biomedical Engineering and recognizes biomedical engineering undergraduate students “with an entrepreneurial spirit, an interest in the local biomedical engineering industry and demonstrated leadership and communication skills.” Hudea is…
Read More
An Artificial Intelligence (AI) platform used to develop precision oncology drugs at the Vancouver Prostate Centre (VPC) has been repurposed to shave significant time off the process of finding a cure for COVID-19. Researchers at the Centre are optimistic that their novel work will provide a list of potential treatment options within a matter of weeks, once they secure the…
Read More
At the Centre for Blood Research (CBR), a team of dedicated trainees who are passionate about sharing science with others, have the unique opportunity to do just that, through the CBR’s Outreach program. Outreach Team members can get involved in many exciting activities including the CBR Blood Labs Program, CBR facility tours, the Elder Scholar lecture series, and special events…
Read More